Beyond Collagen: The Dermal Epidermal Junction

Most conversations about skin ageing stop at collagen and elastin. Advanced skin-ageing research has moved one layer more precise: the dermal-epidermal junction, or DEJ, the structured interface where the epidermis anchors to the dermis.

It is a useful shift. Collagen loss is real, but it is a bulk property of the dermis and a blunt instrument for explaining why skin looks and behaves the way it does. The DEJ gives us something more specific to point at, and in our training sessions it is the concept that most often makes a protocol finally make sense to a practitioner.

What the junction is made of

The DEJ is not a simple boundary. It is an organised basement-membrane zone built from proteins such as collagen IV, collagen VII, collagen XVII and laminins, arranged into anchoring structures that hold the two skin compartments together and mediate communication between them.

Each of those proteins has a job. Collagen XVII is a transmembrane collagen sitting in the hemidesmosomes of the basal keratinocytes, where it links the cell's internal keratin skeleton to laminin-332 in the basement membrane. Collagen IV forms the sheet-like lattice of the basement membrane itself. Collagen VII forms the anchoring fibrils that loop down from the basement membrane into the upper dermis and tie the whole structure into the dermal matrix below. Laminins are the glue between the cells and the sheet. Take any one of them away and adhesion suffers; the inherited blistering diseases are the extreme demonstration of that.

What happens with age

With age and cumulative UV exposure, this junction flattens: the interlocking ridges (rete ridges) that increase surface contact between dermis and epidermis progressively smooth out. A flattened DEJ means less mechanical cohesion, a reduced exchange surface for nutrients, and skin that reads as thinner and less resilient, independent of what is happening to dermal collagen in bulk.

The protein picture changes too. A 2016 review of the DEJ in intrinsic ageing, published in Mechanisms of Ageing and Development, reports reduced distribution of collagen IV, collagen VII, collagen XVII, integrin beta-4 and laminin-332 in aged skin. The review "Skin Structure-Function Relationships and the Wound Healing Response to Intrinsic Aging" describes the same flattening and loss of ridge architecture and links it to slower, less efficient repair.

Collagen XVII has attracted particular attention. Work published in Nature in 2019 on mouse skin showed that basal stem cells with high collagen XVII expression outcompete their neighbours and keep the epidermis young, and that loss of collagen XVII with age and DNA damage tips that balance towards thinning. That is animal data, and it should be read as such, but it is why collagen XVII now appears in formulation briefs as a named marker rather than a footnote.

Why formulators like it

This is why the DEJ is appearing more often in Korean research and formulation briefs: it offers a defined structural target with measurable protein markers, rather than a generic anti-ageing claim. For practitioners, it is also a useful mental model when explaining why resurfacing and regeneration-focused protocols pay attention to the interface between layers as well as the layers themselves.

The questions to ask

A DEJ claim should be held to the same standard as any other. Before accepting one, we suggest asking:

• Which marker? A claim to "support the DEJ" should name a protein (collagen XVII, laminin-332, collagen VII) and say what changed.
• In what model? Cultured keratinocytes, reconstructed skin models and biopsied human skin are three very different levels of evidence.
• By what route? A topical that cannot reach the basal layer cannot act on it. Delivery systems and device-assisted application are part of the answer.
• Supported or rebuilt? "Supports" is a cosmetic claim. "Rebuilds" is a medical one, and it needs a different standard of proof.

What this means in clinic

The DEJ is the reason a combined protocol tends to outperform a single product. Controlled resurfacing and microneedling create a wound-healing response at exactly the interface we are discussing, and the microneedling essentials collection covers the needles, cartridges and aftercare that make that process predictable. Regenerative boosters from the PDRN and regenerative collection are used in the same session to support repair, with the salmon DNA and vesicle products we discuss elsewhere on this blog. Where the goal is laxity and loss of definition rather than texture, practitioners pair that work with the Eclado lifting treatments, and the age management collection holds the home-care that keeps the barrier and basal layer supported between visits.

In consultation, the DEJ gives you a better sentence than "we are boosting collagen". Try: "We are working on the layer where your epidermis attaches to your dermis, because that is where the skin loses its grip with age." Clients understand it, and it is true.

Start with the age management collection or the PDRN and regenerative collection.